We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Oceaneering
OII
$4.75B
| $6.9M | 0.02% |
369,251
-12,957
| -3% | -$223K |
|
627
Vishay Intertechnology
VSH
$4.82B
| $6.86M | 0.02% |
233,403
-18,395
| -7% | -$450K |
|
628
Vanda Pharmaceuticals
VNDA
$302M
| $6.82M | 0.02% |
1,034,328
-10,449
| -1% | -$67K |
|
629
Alarm.com
ALRM
$2.71B
| $6.77M | 0.02% |
130,937
+128,913
| +6,369% | +$6.34M |
|
630
Community Health Systems
CYH
$419M
| $6.76M | 0.02% |
1,535,249
-342,007
| -18% | -$1.46M |
|
631
OptimizeRx
OPRX
$142M
| $6.75M | 0.02% |
472,426
+116,597
| +33% | +$1.66M |
|
|
VTLE
632
DELISTED
Vital Energy
VTLE
| $6.74M | 0.02% |
149,322
+134,616
| +915% | +$6.08M |
|
633
Voyager Therapeutics
VYGR
$190M
| $6.74M | 0.02% |
588,288
-17,330
| -3% | -$179K |
|
634
DraftKings
DKNG
$12.2B
| $6.72M | 0.02% |
252,925
+214,546
| +559% | +$4.94M |
|
|
TWNK
635
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $6.67M | 0.02% |
263,310
-191,871
| -42% | -$4.92M |
|
|
SWI
636
DELISTED
SolarWinds Corporation Common Stock
SWI
| $6.64M | 0.02% |
647,132
+33,066
| +5% | +$301K |
|
637
Take-Two Interactive
TTWO
$39.6B
| $6.61M | 0.02% |
44,922
-32,046
| -42% | -$4.19M |
|
638
Targa Resources
TRGP
$61.3B
| $6.58M | 0.02% |
86,527
-28,704
| -25% | -$2.08M |
|
639
Dynatrace
DT
$15.9B
| $6.58M | 0.02% |
127,906
+8,761
| +7% | +$411K |
|
640
iHeartMedia
IHRT
$408M
| $6.57M | 0.02% |
1,806,257
+91,396
| +5% | +$304K |
|
641
Bruker
BRKR
$8.49B
| $6.57M | 0.02% |
88,815
+74,296
| +512% | +$5.66M |
|
642
L3Harris
LHX
$46.5B
| $6.55M | 0.02% |
33,453
-133
| -0.4% | -$25.4K |
|
643
Cardinal Health
CAH
$54.1B
| $6.48M | 0.02% |
68,512
+61,078
| +822% | +$5.16M |
|
|
GTM
644
ZoomInfo Technologies
GTM
$1.22B
| $6.48M | 0.02% |
255,133
+59,254
| +30% | +$1.4M |
|
|
EB
645
DELISTED
Eventbrite
EB
| $6.45M | 0.02% |
675,137
-216,603
| -24% | -$1.7M |
|
646
Hilton Worldwide
HLT
$69.3B
| $6.35M | 0.02% |
43,621
+16,501
| +61% | +$2.35M |
|
|
ACH
647
Accendra Health
ACH
$85.4M
| $6.35M | 0.02% |
333,326
+154,868
| +87% | +$2.76M |
|
648
Phillips 66
PSX
$106B
| $6.22M | 0.02% |
65,169
+15,878
| +32% | +$1.54M |
|
649
Live Oak Bancshares
LOB
$1.81B
| $6.21M | 0.02% |
236,097
-668,033
| -74% | -$15.7M |
|
650
NeoGenomics
NEO
$2.43B
| $6.14M | 0.02% |
382,242
-235,901
| -38% | -$3.89M |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.